Combination therapy of 5-Fluorouracil/gemcitabine/cisplatin for advanced hepatocellular carcinoma with extrahepatic metastases -A pilot study
Not Applicable
- Conditions
- Hepatocellular carcinoma with extrahepatic metastases
- Registration Number
- JPRN-UMIN000000719
- Lead Sponsor
- Hiroshima University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
With other malignant disease. A pregnant woman, or a woman suspected of pregnancy. With severe infectious disease. With history of severe allergy. With severe renal function disease. With S-1. With severe allergy for 5FU, gemcitabine, or CDDP. With severe bone marrow supression. With pulmonary fibrosis. With the history of radiotharpy for lung.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response for extrahepatic metastases
- Secondary Outcome Measures
Name Time Method Overall survival Safety